TAVRcathAID vs ACC Learn
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
TAVRcathAID
This educational tool provides step-by-step guidance for performing diagnostic coronary angiograms and percutaneous coronary interventions after trans-catheter aortic valve implantation. It features illustrations and animations to aid in understanding complex procedures.
- Step-by-step procedural guidance
- Illustrations and animations
- Focus on post-TAVR interventions
- Diagnostic coronary angiogram guide
- Percutaneous coronary intervention guide
Read full descriptionHide full description
The TAVR CathAID app team comprises of interventional and structural cardiology faculty and fellows at Icahn School of Medicine at Mount Sinai. This app is an educational tool with step by step approach guided by illustrations and aminations to perform diagnostic coronary angiogram and percutaneous coronary intervention after implantation of trans-catheter aortic valve.
ACC Learn
Access select ACC educational products like ACCSAP, CathSAP, and EP SAP on your mobile device. While the app is free, some educational content requires an external purchase.
- Access ACCSAP
- Access CathSAP
- Access EP SAP
- Mobile learning
- Educational content
Read full descriptionHide full description
The ACC Learn App allows you to access select ACC educational products such as ACCSAP, CathSAP, and EP SAP, on your mobile device. The app itself is free, but some of the products available within the app must be purchased outside the app, before you can access them within the app.
Screenshots
Verdict
The clearest difference is update cadence: TAVRcathAID at fortnightly against ACC Learn's every 7 months. TAVRcathAID also leads on monetization model (free vs free with in-app purchases). ACC Learn's advantage is ratings volume (969 vs 5). On price, rating, ads and in-app purchases there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
On the App Store both sit at effectively the same score — 4.6 for TAVRcathAID against 4.6 for ACC Learn. That said, the two scores are not equally well evidenced: ACC Learn has 969 ratings behind it against 5, so its average is the more settled of the two.
TAVRcathAID ships an update fortnightly, ACC Learn every 7 months. The most recent releases landed on October 15, 2026 and October 17, 2026 respectively.
| Parameter | TAVRcathAID | ACC Learn |
|---|---|---|
| Price | Free | Free |
| Rating | 4.6 (5 ratings) | 4.6 (969 ratings) — better |
| Positive reviews | — | 59.5% of reviews |
| Number of ratings | 5 | 969 — better |
| Update frequency | Fortnightly — better | Every 7 months |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free — better | Free with in-app purchases |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 15.0 | 15.0 |
| Further details — not scored | ||
| Size | 49 MB | 28 MB |
| Age rating | 17+ | 17+ |
| Developer | Icahn School of Medicine at Mount Sinai | American College of Cardiology |
Customer experience
TAVRcathAID
ACC Learn
Bugs and requests
TAVRcathAID
Not enough reviews yet to summarise bugs or requests.
ACC Learn
Reported bugs
3 issues- Unable to access content and qbank
- Incompatibility issues on iPad
- Inability to save notes and progress
Requested features
4 requests- Ability to customize learning experience
- Bookmark last accessed content
- Playback speed controls for videos
- Seamless integration between app and website
In-app purchases
TAVRcathAID
No in-app purchases
ACC Learn
No in-app purchases
